Pipeline

Indication

Target

Research

Preclinical

IND Enabling

Phase 1/2

Infection

GPX-501

Treat infection

IND Approved

Moxifloxacin - Moxi-Lens^TM

Glaucoma

GPX-502

IOP reduction

IND Approved

Ocular Cystinosis (Orphan)

GPX-503

Cystine
reduction

IND Approved

Corneal Injury

GPX-504

Corneal
Epithelial
Healing

Post ocular surgery

GPX-505

Protection and pain reduction

Myopia control

GPX-506

TBD

Rare diseases (Back of the Eye, Pediatrics Glaucoma, Severe Keratitis..)

TBD

Indication

Target

Research

Preclinical

IND Enabling

Phase 1/2

Infection

GPX-501

Treat infection

IND Approved

Moxifloxacin - MoxiLens^TM

Glaucoma

GPX-502

IOP reduction

IND Approved

Ocular Cystinosis (Orphan)

GPX-503

Cystine
reduction

IND Approved

Corneal Injury

GPX-504

Corneal
Epithelial
Healing

Post ocular surgery

GPX-505

Protection and pain reduction

Myopia control

GPX-506

TBD

Rare diseases (Back of the Eye, Pediatrics Glaucoma, Severe Keratitis..)

TBD